Michael A. Mussallem, Director at Edwards Lifesciences Corp (EW), sold 430,389 shares at $67.18 ($3.9M) on 2023-11-03, disclosed to the SEC on 2023-11-06.
Scheduled sale ($3.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.18 | 29,350 | $2.0M | 50.0% |
| 2 | $67.18 | 29,350 | $2.0M | 50.0% |
| 3 | $0.00 | 371,689 | $0 | 0.0% |
| Total | $9.16 avg | 430,389 | $3.9M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |